共 8 条
Combined detection of serum UL16-binding protein 2 and macrophage inhibitory cytokine-1 improves early diagnosis and prognostic prediction of pancreatic cancer
被引:19
|作者:
Zhou, Yu-Fen
[1
]
Xu, Ling-Xiao
[1
]
Huang, Li-Ya
[2
]
Guo, Fang
[1
]
Zhang, Fan
[1
]
He, Xiang-Yi
[1
]
Yuan, Yao-Zong
[1
]
Yao, Wei-Yan
[1
]
机构:
[1] Shanghai Jiao Tong Univ, Dept Gastroenterol, Ruijin Hosp, Sch Med, Shanghai 200025, Peoples R China
[2] Ningxia Med Univ, Gen Hosp, Dept Gastroenterol, Ningxia, Peoples R China
关键词:
macrophage inhibitory cytokine-1;
serum biomarker;
pancreatic cancer;
UL16-binding protein 2;
BETA;
CA19-9;
CELLS;
METASTASIS;
MARKERS;
GROWTH;
MEMBER;
TOOL;
D O I:
10.3892/ol.2014.2429
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Pancreatic cancer (PC) is the fourth leading cause of cancer-related mortality in the United States. There is no effective serum biomarker for the early diagnosis of PC at present. Although serum UL16-binding protein 2 (ULBP2) and macrophage inhibitory cytokine-1 (MIC-1) levels are reported to be elevated in PC patients, the diagnostic and prognostic value of ULBP2 and MIC-1 alone or in combination remains unknown. The aim of the present case-control study was to compare the diagnostic value of ULBP2, MIC-1 and carbohydrate antigen 19-9 (CA19-9) in 359 serum samples, consisting of 152 cases of PC, 20 cases of pre-pancreatic cancer, 91 cases of chronic pancreatitis (CP) and 96 normal controls (NC). All patients were followed up for a median of 2 years. It was found that the serum levels of ULBP2, MIC-1 and CA19-9 were significantly higher in the PC patients compared with those in the NC group. In distinguishing PC from the CP, the highest sensitivity and specificity were ULBP2 (0.878) and CA19-9 (0.816), respectively. The area under the receiver operating characteristic curve of ULBP2 was 0.923, which was the highest of the three biomarkers. MIC-1 was the optimal choice for the diagnosis of early-stage PC (area under the curve, 0.831). Overall, MIC-1 in combination with ULBP2 improved the diagnostic accuracy in differentiating PC from CP and NC. In addition, a higher level of MIC-1 was correlated with a poorer prognosis, as calculated by the Kaplan-Meier test (P=0.039). Patients with serum MIC-1 levels of >= 1,932 ng/ml had a median survival time of 15.62 +/- 2.44 months (mean +/- standard deviation) vs. 18.66 +/- 2.43 months in patients with a lower level of MIC-1. Overall, combined detection of serum MIC-1 and ULBP2 improved the diagnostic accuracy in differentiating PC from CP and NC, and serum MIC-1 level alone was a predictor of survival in the patients with PC.
引用
收藏
页码:2096 / 2102
页数:7
相关论文